Full name
EXPLORNA THERAPEUTICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
EXPLORNA THERAPEUTICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ŻWIRKI I WIGURY 93 / 2157, 02-089 WARSZAWA
TAX ID7010925631
Rate company:
EXPLORNA THERAPEUTICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7010925631
KRS0000786638
Share capital9,100.00 zł
address
UL. ŻWIRKI I WIGURY 93 / 2157, 02-089 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7010925631
REGON
383377311
KRS
0000786638
Legal form
limited liability company
Register Address
UL. ŻWIRKI I WIGURY 93 / 2157, 02-089 WARSZAWA
Date of registration in KRS
2019-05-16
Date of commencement of economic activity
2019-05-16
Act signature
RDF/603001/24/363
Pkd codes
72.11.Z - Research and experimental development on biotechnology
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
84.12.Z - Regulation of the activities of providing health care, education, cultural services and other social services, excluding social security
85.60.Z - Educational support activities
86.90.E - Other human health activities notelsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL87 1140 2004 0000 3502 7989 1470 
PL48 1140 2004 0000 3212 1242 8688 
PL06 1090 2590 0000 0001 5196 1835 PL59 1090 2590 0000 0001 5153 7767 PL28 1090 2590 0000 0001 5153 7743 PL92 1090 2590 0000 0001 5153 7852 PL29 1090 2590 0000 0001 5153 7725 PL08 1140 2004 0000 3202 7985 0650 PL42 1140 2004 0000 3202 7985 1008 PL42 1140 2004 0000 3412 1104 4023 PL61 1140 2004 0000 3902 8025 8693 Show more bank accounts from VAT list (8)
EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | -9,7 | -4,5 | -11,6 | -159,3 |
Gross profit (loss) | -6,7 | -0,2 | -7,2 | -3806,2 |
EBITDA | -6,1 | 0,3 | -4,6 | -1560,7 |
Short time liabilities | 5,4 | 1,1 | 1,1 | 4,7 |
Other operating costs | 0 | 0 | 0 | 3574,5 |
Income tax | ||||
Equity capital | 11,4 | 30,7 | 33,4 | 9 |
Operating profit (EBIT) | -6,7 | -0,2 | -7,6 | -4569,9 |
Assets | 16,9 | 35,3 | 34,6 | -2 |
Net profit (loss) | -6,7 | -0,2 | -7,2 | -3806,2 |
Cash | 14,9 | 22,8 | 5,1 | -77,8 |
Net income from sale | 0,3 | 1,1 | 0,7 | -34,5 |
Liabilities and provisions for liabilities | 5,5 | 4,6 | 1,1 | -75,3 |
Working assets | 15,3 | 32,6 | 24,8 | -23,9 |
Other income costs | 2,9 | 4,3 | 4 | -6,9 |
Depreciation | 0,6 | 0,5 | 3 | 519,2 |
Basic operational activity income | ||||
% | % | % | p.p. | |
Profitability of capital | -58,9 | -0,6 | -21,7 | -21,1 |
Equity capital to total assets | 67,7 | 87 | 96,7 | 9,7 |
Gross profit margin | -2181,8 | -17,6 | -1048,8 | -1031,2 |
EBITDA Margin | -1975,1 | 30,1 | -672,2 | -702,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 6380 | 374 | 598 | 224 |
Current financial liquidity indicator | 2.848667860031128 | 30.207977294921875 | 21.955677032470703 | -8,2 |
Net dept to EBITDA | 2.4433887004852295 | -71.71882629394531 | 1.0909557342529297 | 72,8 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Molecular Biotech Mateusz Gielata
Warszawa
Bioenola sp. z o.o. w likwidacji
Olsztyn
4CAE Krzysztof Matusiak
Warszawa